Bebac user
☆    

Egypt,
2025-02-25 21:30
(469 d 11:32 ago)

Posting: # 24376
Views: 3,003
 

 Question about Williams Design [Design Issues]

Post reply
Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.
 
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
211 visitors (0 registered, 211 guests [including 17 identified bots]).
Forum time: 10:02 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5